M'Koma Amosy E
Meharry Medical College School of Medicine, Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Nashville, TN 37208, USA.
Vanderbilt University School of Medicine, Department of Surgery, Colon and Rectal Surgery, Nashville, TN 37232, USA.
Gastrointest Disord (Basel). 2019 Mar;1(1):75-105. doi: 10.3390/gidisord1010007. Epub 2018 Oct 18.
The gastrointestinal system where inflammatory bowel disease occurs is central to the immune system where the innate and the adaptive/acquired immune systems are balanced in interactions with gut microbes under homeostasis conditions. This article overviews the high-throughput research screening on multifactorial interplay between genetic risk factors, the intestinal microbiota, urbanization, modernization, Westernization, the environmental influences and immune responses in the etiopathogenesis of inflammatory bowel disease in humans. Inflammatory bowel disease is an expensive multifactorial debilitating disease that affects thousands new people annually worldwide with no known etiology or cure. The conservative therapeutics focus on the established pathology where the immune dysfunction and gut injury have already happened but do not preclude or delay the progression. Inflammatory bowel disease is evolving globally and has become a global emergence disease. It is largely known to be a disease in industrial-urbanized societies attributed to modernization and Westernized lifestyle associated with environmental factors to genetically susceptible individuals with determined failure to process certain commensal antigens. In the developing nations, increasing incidence and prevalence of inflammatory bowel disease (IBD) has been associated with rapid urbanization, modernization and Westernization of the population. In summary, there are identified multiple associations to host exposures potentiating the landscape risk hazards of inflammatory bowel disease trigger, that include: Western life-style and diet, host genetics, altered innate and/or acquired/adaptive host immune responses, early-life microbiota exposure, change in microbiome symbiotic relationship (dysbiosis/dysbacteriosis), pollution, changing hygiene status, socioeconomic status and several other environmental factors have long-standing effects/influence tolerance. The ongoing multipronged robotic studies on gut microbiota composition disparate patterns between the rural vs. urban locations may help elucidate and better understand the contribution of microbiome disciplines/ecology and evolutionary biology in potentially protecting against the development of inflammatory bowel disease.
炎症性肠病发生的胃肠道系统是免疫系统的核心,在稳态条件下,先天免疫系统与适应性/后天免疫系统在与肠道微生物的相互作用中保持平衡。本文概述了关于遗传风险因素、肠道微生物群、城市化、现代化、西方化、环境影响和免疫反应在人类炎症性肠病发病机制中的多因素相互作用的高通量研究筛选。炎症性肠病是一种代价高昂的多因素致残性疾病,全球每年有数千人受其影响,病因不明且无法治愈。保守治疗侧重于已形成的病理状况,即免疫功能障碍和肠道损伤已经发生,但不能预防或延缓疾病进展。炎症性肠病正在全球范围内演变,已成为一种全球新兴疾病。人们普遍认为,在工业化的城市社会中,这种疾病归因于现代化和西方化的生活方式,以及与环境因素相关的、对某些共生抗原处理能力有缺陷的遗传易感性个体。在发展中国家,炎症性肠病(IBD)发病率和患病率的上升与人口的快速城市化、现代化和西方化有关。总之,已确定多种与宿主暴露相关的因素增加了炎症性肠病触发的风险,包括:西方生活方式和饮食、宿主遗传学、先天和/或后天/适应性宿主免疫反应改变、早期微生物群暴露、微生物组共生关系的变化(生态失调/菌群失调)、污染、卫生状况改变、社会经济地位以及其他几个环境因素对耐受性有长期影响。正在进行的关于农村与城市地区肠道微生物群组成差异模式的多方面研究,可能有助于阐明并更好地理解微生物组学科/生态学和进化生物学在潜在预防炎症性肠病发展中的作用。